Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Wolfe downgrades Zions, Cullen/Frost to neutral after outperformance » 06:47
11/03/22
11/03
06:47
11/03/22
06:47
ZION

Zions Bancorp

$49.49 /

-2.1 (-4.07%)

, CFR

Cullen/Frost

$155.61 /

-0.9 (-0.58%)

Wolfe Research analyst…

Wolfe Research analyst Bill Carcache last night downgraded both Zions Bancorp (ZION) and Cullen/Frost (CFR) to Peer Perform from Outperform without a price targets. Both banks have outperformed mid-cap peers year-to-date but are most exposed to investor sentiment shifts around tangible capital as they are running with the lowest levels of tangible common equity, Carcache tells investors in a research note. With the stocks shares hovering near his prior price targets, the analyst sees more limited upside.

ShowHide Related Items >><<
ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

11/02/22 Wolfe Research
Zions Bancorp downgraded to Peer Perform from Outperform at Wolfe Research
10/25/22 DA Davidson
Zions Bancorp price target lowered to $56 from $61 at DA Davidson
10/25/22 Wedbush
Zions Bancorp price target lowered to $50 from $61 at Wedbush
10/25/22 Wells Fargo
Zions Bancorp price target lowered to $55 from $66 at Wells Fargo
CFR Cullen/Frost
$155.61 /

-0.9 (-0.58%)

11/02/22 Wolfe Research
Cullen/Frost downgraded to Peer Perform from Outperform at Wolfe Research
10/31/22 Truist
Cullen/Frost price target raised to $160 from $150 at Truist
10/31/22 Evercore ISI
Cullen/Frost upgraded to In Line from Underperform at Evercore ISI
10/28/22 Raymond James
Cullen/Frost price target raised to $165 from $150 at Raymond James
ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

CFR Cullen/Frost
$155.61 /

-0.9 (-0.58%)

ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

CFR Cullen/Frost
$155.61 /

-0.9 (-0.58%)

Downgrade
Zions Bancorp downgraded to Peer Perform from Outperform at Wolfe Research » 18:11
11/02/22
11/02
18:11
11/02/22
18:11
ZION

Zions Bancorp

$49.49 /

-2.1 (-4.07%)

Wolfe Research analyst…

Wolfe Research analyst Bill Carcache downgraded Zions Bancorp to Peer Perform from Outperform. The analyst cites tangible common equity "tail risks" for the downgrade.

ShowHide Related Items >><<
ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

10/25/22 DA Davidson
Zions Bancorp price target lowered to $56 from $61 at DA Davidson
10/25/22 Wedbush
Zions Bancorp price target lowered to $50 from $61 at Wedbush
10/25/22 Wells Fargo
Zions Bancorp price target lowered to $55 from $66 at Wells Fargo
10/25/22 Barclays
Zions Bancorp price target lowered to $68 from $71 at Barclays
ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

ZION Zions Bancorp
$49.49 /

-2.1 (-4.07%)

Hot Stocks
Zions Bancorp approves Q4 share repurchase for up to $50M » 14:15
10/28/22
10/28
14:15
10/28/22
14:15
ZION

Zions Bancorp

$51.26 /

+0.92 (+1.83%)

Zions Bancorporation…

Zions Bancorporation announced that its board authorized a share repurchase for Q4 of up to $50M. The board also declared a regular quarterly dividend of 41c per common share, payable November 17, to shareholders of record at the close of business on November 10.

ShowHide Related Items >><<
ZION Zions Bancorp
$51.26 /

+0.92 (+1.83%)

ZION Zions Bancorp
$51.26 /

+0.92 (+1.83%)

10/25/22 DA Davidson
Zions Bancorp price target lowered to $56 from $61 at DA Davidson
10/25/22 Wedbush
Zions Bancorp price target lowered to $50 from $61 at Wedbush
10/25/22 Wells Fargo
Zions Bancorp price target lowered to $55 from $66 at Wells Fargo
10/25/22 Barclays
Zions Bancorp price target lowered to $68 from $71 at Barclays
ZION Zions Bancorp
$51.26 /

+0.92 (+1.83%)

ZION Zions Bancorp
$51.26 /

+0.92 (+1.83%)

Recommendations
Zions Bancorp price target lowered to $56 from $61 at DA Davidson » 08:51
10/25/22
10/25
08:51
10/25/22
08:51
ZION

Zions Bancorp

$49.80 /

+2.02 (+4.23%)

DA Davidson transferred…

DA Davidson transferred coverage of Zions Bancorp to analyst Peter Winter, who keeps a Neutral rating with a lower price target of $56, down from $61, after its Q3 earnings miss. The bank's net interest income outlook still remains positive but slowing similar to peers, with a better than peer deposit beta outcome through the rate cycle, the analyst tells investors in a research note. Winter is also cutting DA Davidson outlook for Zions FY22 EPS to $5.70 from $5.93 but raising the FY23 view to $6.86 from $6.78.

ShowHide Related Items >><<
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

10/25/22 Wedbush
Zions Bancorp price target lowered to $50 from $61 at Wedbush
10/25/22 Wells Fargo
Zions Bancorp price target lowered to $55 from $66 at Wells Fargo
10/25/22 Barclays
Zions Bancorp price target lowered to $68 from $71 at Barclays
10/25/22 Piper Sandler
Zions Bancorp price target lowered to $60 from $66 at Piper Sandler
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

Recommendations
Zions Bancorp price target lowered to $50 from $61 at Wedbush » 07:31
10/25/22
10/25
07:31
10/25/22
07:31
ZION

Zions Bancorp

$49.80 /

+2.02 (+4.23%)

Wedbush analyst David…

Wedbush analyst David Chiaverini lowered the firm's price target on Zions Bancorp to $50 from $61 and keeps a Neutral rating on the shares. The analyst notes the company reported a weak quarter headlined by deposit runoff, increased expenses, and higher-than-expected loan loss provision. While roughly in-line NIM expansion and loan growth were positives, they were more than offset by deposit runoff, which caused average earnings assets to decline meaningfully for the second straight quarter, Chiaverini adds.

ShowHide Related Items >><<
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

10/25/22 Wells Fargo
Zions Bancorp price target lowered to $55 from $66 at Wells Fargo
10/25/22 Barclays
Zions Bancorp price target lowered to $68 from $71 at Barclays
10/25/22 Piper Sandler
Zions Bancorp price target lowered to $60 from $66 at Piper Sandler
10/06/22 Keefe Bruyette
KBW recommends pair trade of overweight Comerica, underweight Zions
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

Recommendations
Zions Bancorp price target lowered to $55 from $66 at Wells Fargo » 07:06
10/25/22
10/25
07:06
10/25/22
07:06
ZION

Zions Bancorp

$49.80 /

+2.02 (+4.23%)

Wells Fargo analyst Mike…

Wells Fargo analyst Mike Mayo lowered the firm's price target on Zions Bancorp to $55 from $66 and keeps an Equal Weight rating on the shares. Zions reported core Q3 EPS of $1.54 versus consensus of $1.56 due to higher-than-expected loan loss reserve builds and operating expenses, offset by higher-than-expected net interest income growth, the analyst notes. The quarter highlight was positive operating leverage and good net interest income guidance leading Mayo to increase 2023-2024 EPS by 5% on average. On the other hand, book value deteriorated 18% quarter-over-quarter due in part to a $1B impact from AOCI, and this leads him to lower his target.

ShowHide Related Items >><<
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

10/25/22 Barclays
Zions Bancorp price target lowered to $68 from $71 at Barclays
10/25/22 Piper Sandler
Zions Bancorp price target lowered to $60 from $66 at Piper Sandler
10/06/22 Keefe Bruyette
KBW recommends pair trade of overweight Comerica, underweight Zions
10/06/22 Keefe Bruyette
Keefe Bruyette downgrades Zions to Market Perform into Q3 results
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

Recommendations
Zions Bancorp price target lowered to $68 from $71 at Barclays » 06:22
10/25/22
10/25
06:22
10/25/22
06:22
ZION

Zions Bancorp

$49.80 /

+2.02 (+4.23%)

Barclays analyst Jason…

Barclays analyst Jason Goldberg lowered the firm's price target on Zions Bancorp to $68 from $71 and keeps an Equal Weight rating on the shares post the Q3 results. Earnings fell short as higher than expected net interest income was more than offset by higher than forecast expenses and provision, Goldberg tells investors in a research note.

ShowHide Related Items >><<
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

10/25/22 Piper Sandler
Zions Bancorp price target lowered to $60 from $66 at Piper Sandler
10/06/22 Keefe Bruyette
KBW recommends pair trade of overweight Comerica, underweight Zions
10/06/22 Keefe Bruyette
Keefe Bruyette downgrades Zions to Market Perform into Q3 results
10/06/22 Keefe Bruyette
Zions Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

Recommendations
Zions Bancorp price target lowered to $60 from $66 at Piper Sandler » 06:12
10/25/22
10/25
06:12
10/25/22
06:12
ZION

Zions Bancorp

$49.80 /

+2.02 (+4.23%)

Piper Sandler analyst…

Piper Sandler analyst Brad Milsaps lowered the firm's price target on Zions Bancorp to $60 from $66 and keeps an Overweight rating on the shares. Zion's Q3 results were less than expected due to a larger LLP and higher expenses, which offset better net interest income versus the consensus, Milsaps tells investors in a research note.

ShowHide Related Items >><<
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

10/06/22 Keefe Bruyette
KBW recommends pair trade of overweight Comerica, underweight Zions
10/06/22 Keefe Bruyette
Keefe Bruyette downgrades Zions to Market Perform into Q3 results
10/06/22 Keefe Bruyette
Zions Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
09/28/22 Wedbush
Zions Bancorp assumed with a Neutral at Wedbush
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

On The Fly
Fly Intel: After-Hours Movers » 18:53
10/24/22
10/24
18:53
10/24/22
18:53
MEDP

Medpace

$158.72 /

+1.84 (+1.17%)

, XM

Qualtrics

$10.46 /

-0.105 (-0.99%)

, CLS

Celestica

$9.53 /

+0.275 (+2.97%)

, FLXS

Flexsteel Industries

$13.83 /

-0.04 (-0.29%)

, SSB

South State

$85.79 /

+0.23 (+0.27%)

, CDNS

Cadence Design

$160.20 /

+1.82 (+1.15%)

, ADTN

Adtran

$19.30 /

+0.22 (+1.15%)

, CCK

Crown Holdings

$84.98 /

+1.075 (+1.28%)

, HSII

Heidrick & Struggles

$28.63 /

-0.28 (-0.97%)

, ZION

Zions Bancorp

$49.80 /

+2.02 (+4.23%)

, CR

Crane

$99.76 /

-0.175 (-0.18%)

, WRB

W. R. Berkley

$72.55 /

+1.34 (+1.88%)

, TBI

TrueBlue

$21.68 /

-0.18 (-0.82%)

, DFS

Discover

$95.80 /

+1.13 (+1.19%)

, BRO

Brown & Brown

$63.11 /

+1.485 (+2.41%)

Check out this evening's…

ShowHide Related Items >><<
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

SSB South State
$85.79 /

+0.23 (+0.27%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CR Crane
$99.76 /

-0.175 (-0.18%)

CLS Celestica
$9.53 /

+0.275 (+2.97%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

CCK Crown Holdings
$84.98 /

+1.075 (+1.28%)

BRO Brown & Brown
$63.11 /

+1.485 (+2.41%)

ADTN Adtran
$19.30 /

+0.22 (+1.15%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

09/07/22 UBS
Medpace initiated with a Sell at UBS
05/23/22 Guggenheim
Medpace initiated with Neutral on pre-revenue focus at Guggenheim
05/23/22 Guggenheim
Medpace initiated with a Neutral at Guggenheim
03/17/22 Baird
Medpace price target raised to $175 from $160 at Baird
XM Qualtrics
$10.46 /

-0.105 (-0.99%)

10/19/22 Morgan Stanley
Qualtrics price target lowered to $14 from $17 at Morgan Stanley
10/18/22 Barclays
Qualtrics price target lowered to $11 from $16 at Barclays
10/03/22 Exane BNP Paribas
Qualtrics upgraded to Outperform from Neutral at Exane BNP Paribas
08/09/22 HSBC
Qualtrics price target lowered to $20 from $40 at HSBC
CLS Celestica
$9.53 /

+0.275 (+2.97%)

08/18/22 Argus
Celestica upgraded to Buy at Argus amid strong year-to-date results
08/18/22 Argus
Celestica upgraded to Buy from Hold at Argus
07/27/22 BMO Capital
Celestica upgraded to Outperform from Market Perform at BMO Capital
07/27/22 Canaccord
Celestica positioned well despite headwinds, says Canaccord
FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

SSB South State
$85.79 /

+0.23 (+0.27%)

09/28/22 Piper Sandler
South State upgraded to Overweight from Neutral at Piper Sandler
08/01/22 Truist
South State price target raised to $97 from $90 at Truist
06/15/22 Truist
South State price target lowered to $90 from $92 at Truist
06/02/22 Keefe Bruyette
South State upgraded to Outperform from Market Perform at Keefe Bruyette
CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

10/24/22 Rosenblatt
Cadence Design price target lowered to $175 from $185 at Rosenblatt
09/29/22 Deutsche Bank
Cadence Design initiated with a Buy at Deutsche Bank
09/07/22 Stifel
Stifel starts Cadence Design at Hold, prefers Synopsys on valuation basis
09/07/22 Stifel
Cadence Design initiated with a Hold at Stifel
ADTN Adtran
$19.30 /

+0.22 (+1.15%)

09/26/22 Loop Capital
Adtran upgraded to Buy from Hold at Loop Capital
09/26/22 Loop Capital
Adtran upgraded to Buy from Hold at Loop Capital
09/13/22 WestPark Capital
Adtran initiated with a Hold at WestPark Capital
07/14/22 Needham
Adtran initiated with a Buy at Needham
CCK Crown Holdings
$84.98 /

+1.075 (+1.28%)

10/24/22 Deutsche Bank
Crown Holdings price target lowered to $109 from $115 at Deutsche Bank
10/24/22 Mizuho
Crown Holdings price target lowered to $112 from $124 at Mizuho
10/14/22 RBC Capital
Crown Holdings price target lowered to $110 from $122 at RBC Capital
10/13/22 BofA
Crown Holdings price target lowered to $105 from $106 at BofA
HSII Heidrick & Struggles
$28.63 /

-0.28 (-0.97%)

07/28/22 Barrington
Heidrick & Struggles price target lowered to $45 from $54 at Barrington
07/15/22 Truist
Heidrick & Struggles price target lowered to $30 from $50 at Truist
04/27/22 Barrington
Heidrick & Struggles price target raised to $54 from $50 at Barrington
10/28/21 Barrington
Heidrick & Struggles price target raised to $53 from $50 at Barrington
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

10/06/22 Keefe Bruyette
KBW recommends pair trade of overweight Comerica, underweight Zions
10/06/22 Keefe Bruyette
Keefe Bruyette downgrades Zions to Market Perform into Q3 results
10/06/22 Keefe Bruyette
Zions Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
09/28/22 Wedbush
Zions Bancorp assumed with a Neutral at Wedbush
CR Crane
$99.76 /

-0.175 (-0.18%)

10/11/22 Stifel
Crane price target lowered to $121 from $123 at Stifel
04/18/22 Stifel
Crane price target lowered to $134 from $137 at Stifel
12/03/21 Morgan Stanley
Crane initiated with an Equal Weight at Morgan Stanley
10/26/21 DA Davidson
Crane price target raised to $125 from $115 at DA Davidson
WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

09/05/22 Keefe Bruyette
W. R. Berkley upgraded to Outperform from Market Perform at Keefe Bruyette
08/03/22 Argus
W. R. Berkley initiated with a Buy at Argus
08/03/22 Argus
W. R. Berkley initiated with a Buy at Argus
07/12/22 Jefferies
W. R. Berkley price target raised to $70 from $67 at Jefferies
TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

07/26/22 Baird
TrueBlue price target lowered to $28 from $36 at Baird
05/26/22 BMO Capital
TrueBlue downgraded to Market Perform from Outperform at BMO Capital
04/11/22 Sidoti
TrueBlue reinstated with a Buy at Sidoti
10/26/21 Baird
TrueBlue price target raised to $35 from $31 at Baird
DFS Discover
$95.80 /

+1.13 (+1.19%)

10/13/22 Citi
Discover price target lowered to $103 from $115 at Citi
10/13/22 Barclays
Discover price target lowered to $115 from $133 at Barclays
09/26/22 Piper Sandler
Discover price target lowered to $124 from $132 at Piper Sandler
09/06/22 JPMorgan
Discover downgraded on more cautious consumer outlook at JPMorgan
BRO Brown & Brown
$63.11 /

+1.485 (+2.41%)

10/07/22 Jefferies
Brown & Brown price target raised to $74 from $70 at Jefferies
07/27/22 RBC Capital
Brown & Brown price target lowered to $66 from $71 at RBC Capital
07/18/22 Truist
Brown & Brown price target lowered to $75 from $82 at Truist
07/12/22 Jefferies
Brown & Brown price target lowered to $70 from $82 at Jefferies
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

SSB South State
$85.79 /

+0.23 (+0.27%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

HSII Heidrick & Struggles
$28.63 /

-0.28 (-0.97%)

FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CR Crane
$99.76 /

-0.175 (-0.18%)

CLS Celestica
$9.53 /

+0.275 (+2.97%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

CCK Crown Holdings
$84.98 /

+1.075 (+1.28%)

BRO Brown & Brown
$63.11 /

+1.485 (+2.41%)

ADTN Adtran
$19.30 /

+0.22 (+1.15%)

  • 05
    Nov
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

SSB South State
$85.79 /

+0.23 (+0.27%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

ADTN Adtran
$19.30 /

+0.22 (+1.15%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

Earnings
Zions Bancorp reports Q3 EPS $1.40, consensus $1.58 » 16:14
10/24/22
10/24
16:14
10/24/22
16:14
ZION

Zions Bancorp

$49.72 /

+1.935 (+4.05%)

Reports Q3 net interest…

Reports Q3 net interest margin 3.24% vs. 2.68% y/y. Reports Q3 provision for loan loss $71M vs. $41M in Q2. Harris H. Simmons, CEO, commented, "Our third quarter results continued to demonstrate the positive impact of solid loan growth and moderately higher interest rates, as our net interest margin strengthened to 3.24%, up from 2.68% a year ago, producing strong adjusted pre-provision net revenue growth and positive operating leverage. Strong PPNR growth was offset by a higher provision for credit losses. Despite material improvements in most of our credit quality metrics relative to both last quarter and last year, we boosted our loan loss reserve to reflect both loan growth and a heightened probability of economic recession in the coming year."

ShowHide Related Items >><<
ZION Zions Bancorp
$49.72 /

+1.935 (+4.05%)

ZION Zions Bancorp
$49.72 /

+1.935 (+4.05%)

10/06/22 Keefe Bruyette
KBW recommends pair trade of overweight Comerica, underweight Zions
10/06/22 Keefe Bruyette
Keefe Bruyette downgrades Zions to Market Perform into Q3 results
10/06/22 Keefe Bruyette
Zions Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
09/28/22 Wedbush
Zions Bancorp assumed with a Neutral at Wedbush
ZION Zions Bancorp
$49.72 /

+1.935 (+4.05%)

ZION Zions Bancorp
$49.72 /

+1.935 (+4.05%)

ZION Zions Bancorp
$49.72 /

+1.935 (+4.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.